LOGIN
Modified release prednisone a better option at reducing morning stiffness in RA
March 2013
Modified release prednisone a better option at reducing morning stiffness in RA
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:N/A
Efficacy of modified-release versus standard prednisone to reduce duration of morning stiffness of the joints in rheumatoid arthritis (CAPRA-1): A double-blind, randomised controlled trial
Lancet. 2008 Jan 19;371(9608):205-14.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
288 patients, between the age of 18 to 80, with active rheumatoid arthritis (RA) were randomly assigned to be administered either a modified-release prednisone tablet or an immediate-release prednisone tablet. Modified-release prednisone was a safe and well tolerated drug that produced a clinically relevant reduction of morning stiffness of the joints. In addition, it provided well known therapeut...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.